ClinicalTrials.gg
RecruitingNCT05110989REDUCEUpdated Jun 29, 2026

A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves

An observational study in Post Operative Pain, sponsored by AtriCure, Inc.. Recruiting at 11 sites in 5 countries. Open to participants aged 12 Years and older. Per ClinicalTrials.gov, last updated 2026-06-29.

Sponsored by AtriCure, Inc. · Observational

How we know

From the registry’s dates

  • Started Jun 2018; still recruiting 8 years 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
5,000
Ages
12 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,181 studies in Pain, Postoperative with a site in United States — 204 open to participants now, 237 under way, 25 of them phase 3. Pain, Postoperative · United States.

Planned enrollment
2nd of 82
5,000 · median 130
Started
2018
with 73 others
Observational
82 of 1,181
18 open now
Primary completion
2035-01
later than 236 of 236 live
Registered
871st of 1,181
by date

Among the 1,181 studies in Pain, Postoperative with a site in United States, this one is the 2nd largest by planned enrollment of the 82 observational ones that give a count, is one of 74 that started in 2018, is one of 82 observational ones, reaches primary completion later than 236 of the 236 other live ones, and was the 871st registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

204 of the 1,181 studies in Pain, Postoperative with a site in United States are open now. Recruiting first, the newest first:

199 more — sign in →

All 204 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 12 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,181 studies in Pain, Postoperative with a site in United States, or all of them as a file.
02

Study summary

This is a retrospective and prospective, multicenter, observational patient registry to record outcomes from patients undergoing cryoablation of the intercostal nerves (cryoanalgesia) for post-operative pain management.

03

Conditions studied

  • Post Operative Pain

Browse trials for

04

Who can participate

Ages eligible
12 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The REDUCE registry eligibility is open to sites and physicians performing cryo nerve block procedures as treatments for patients to generate croanalgesia as a post operative pain management method using the AtriCure Cryo Nerve Block (cryoNB) Device Family. Subjects must have been scheduled to undergo or have undergone the cryo nerve block procedure and must meet all eligibility criteria in order for their treatment and results to be considered for this registry.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients whose age is 12 years or above, and are able to give /assent specific to state and national law.
  2. Patients have been scheduled by physician(s) to undergo or have undergone cryoablation of the intercostal nerves utilizing at least one AtriCure device or are similar patients treated without the use of cryoablation

Exclusion criteria

Exclusion Criteria:

  1. Patient is enrolled in a concurrent trial that may impact the treatment offered by the registry devices.
  2. Patient with exclusion criteria required by local governance.
  3. Women of who are, or plan to become, pregnant during the time of the study
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Childbearing potential

Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).

Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.

05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
5,000 participants (estimated)
Target follow-up
5 Years
Patient registry
Yes

Interventions

  • DeviceAtriCure Cryo Nerve Block (cryoNB) Device Family

    Use of Atricure Cryo Nerve Block Device Family to generate cryoanalgesia for the management of post operative pain.

06

What researchers measure

Primary outcomes

  1. Efficacy of cryo nerve block to generate cryoanalgesia as post operative pain management

    Collect pain score to assess the effect of cryoanalgesia effect with a follow up duration of up to 5 years.

    Time frame: From enrollment to 5 years after date of index procedure

  2. Safety of cryo nerve block to generate cryoanalgesia as post operative pain management

    Collect adverse events occurred during and post operation to assess the safety of the cryo nerve block procedure.

    Time frame: From enrollment to 5 years after date of index procedure

07

Study locations

10 of 11 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2018 (actual). Primary completion is estimated for Jan 2035, 199 months after the start.

Of 396 observational studies under Pain, Postoperative, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 33. This study's planned 199 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 28, 2021
First posted
Nov 8, 2021
StartActual
Jun 29, 2018
Primary completionEst.
Jan 2035
CompletionEst.
Jan 2040
Last update
Jun 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05110989
Lead sponsor
AtriCure, Inc.
Responsible party
Sponsor
First posted
Nov 8, 2021
Start date
Jun 29, 2018
Primary completion
Jan 2035 (estimated)
Completion
Jan 2040 (estimated)
Last update
Jun 29, 2026

Study contacts

Elizabeth Menard
Contact
REDUCE-REGISTRY@atricure.com
8327120715
Laura O'Brien, PhD
Contact
lobrien@atricure.com
763-310-6151
Curits Quinn, MD
principal investigator · Elliot Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion